Among the members of the Bcl-2 family, the multidomain proteins Bax and Bak are crucial for the activation of mitochondria. However, it is still unclear whether they act in a unique and distinct manner or whether they exhibit redundant functions. To systematically investigate their activation on a single-cell level, we established MCF-7 cell lines stably expressing GFP-fusion variants of these proteins. We found that MCF-7/GFP-Bak cells showed an increased sensitivity to apoptosis induction by staurosporine, actinomycin D, TRAIL and overexpression of Puma compared to GFP-Bax-expressing cells. Independently of the death stimulus used, oligomerization of endogenous and exogenous Bak was mostly detected prior to an activation of Bax, whereas cells displaying oligomerized Bax in the absence of Bak clusters were not observed. In addition, activation of Bax but not Bak was attenuated by a caspase inhibitor. Consistent with this, caspase-3-deficient MCF-7 cells displayed a significantly reduced activation of endogenous Bax than caspase-3-proficient MCF-7 cells. Thus, our data strongly suggest that diverse apoptotic stimuli preferentially engage the Bak pathway, whereas the triggering of Bax occurs, at least partially, downstream of mitochondrial caspase activation, most likely constituting a positive feedback loop for the amplification of the death signal.
Introduction
The mechanisms underlying apoptosis have been studied for more than 20 years now and detailed models of the two major signaling routes including the extrinsic and intrinsic death pathways are well established (Schulze-Osthoff et al., 1998; Kroemer and Reed, 2000) . Whereas extrinsically triggered apoptosis is mediated by death receptors (CD95/Fas/APO-1; tumor necrosis factor receptor, TNF-R; TNF-related apoptosis-inducing ligand receptor, TRAIL-R), the intrinsic death pathway is instigated by activation of the mitochondria. Their subsequent release of cytochrome c is a prerequisite for the assembly of the apoptosome, a high-molecular weight complex consisting of cytochrome c, apoptotic protease-activating factor 1 and caspase-9 (Schwerk and Schulze-Osthoff, 2005) . Similarly to the death receptor-mediated activation of caspase-8 in the death-inducing signaling complex (DISC), apoptosome formation results in the autocatalytic activation of caspase-9 (Pop et al., 2006) .
Obviously, both death pathways require a tight control to prevent their untimely induction. Whereas the death receptor pathway is regulated by antiapoptotic proteins such as the caspase-8 inhibitor c-FLIP, activation of the mitochondria is mainly controlled by members of the Bcl-2 family that can be divided into antiapoptotic and proapoptotic proteins (Letai, 2005) . The latter class is further subdivided into proapoptotic multidomain and so-called BH3-only proteins. Solely based on protein-protein interactions, antiapoptotic Bcl-2 members (for example, Bcl-2, Bcl-x L ) antagonize the proapoptotic pore-forming capability of the multidomain Bcl-2 proteins (Bax, Bak, Bok) that upon activation change their conformation and oligomerize into clusters at the outer mitochondrial membrane, leading to the release of cytochrome c (Waterhouse et al., 2002; Daniel et al., 2003) .
Presently, two models are being discussed for the activation of proapoptotic multidomain proteins that both rely on the presence of BH3-only proteins. One model-the direct activation model-proposes the necessity of a transient 'hit-and-run' by a direct interaction between activating BH3-only proteins (for example, Bid, Bim, Puma) and the multidomain proteins Bax and Bak. This activation is further accelerated by so-called sensitizing BH3-only proteins (for example, Bad, Noxa) that release the activators from binding to antiapoptotic proteins (Lindsten et al., 2000; Letai et al., 2002; Kim et al., 2006) . In the second model, BH3-only proteins do not directly interact with Bax or Bak, but are postulated to accomplish their apoptosis-inducing task by releasing Bax or Bak from their antiapoptotic binding partners (Willis et al., , 2007 . Nevertheless, in both models BH3-only proteins ultimately lead to the oligomerization of Bax and Bak in the outer mitochondrial membrane and subsequent instigation of the intrinsic death pathway (Reed, 2006) .
The essential role of Bax and/or Bak for the activation of mitochondria is supported by Bax and Bak knockout models. Cells lacking both Bax and Bak do not die in response to various apoptotic stimuli proteins, in contrast to cells expressing either one of these molecules (Wei et al., 2001) . This provided the insight that BH3-only proteins require at least one Bcl-2 multidomain protein to induce cell death. However, it is still controversial whether Bax and Bak act in a unique and distinct manner or whether they merely exhibit redundant roles. Thus, it was shown that induction of apoptosis by certain death stimuli depends either on the presence of Bax or Bak, therefore indicating unique roles for each of these proteins (Wang et al., 2001; Cartron et al., 2003; Yamaguchi et al., 2003; Dansen et al., 2006) . This discrepancy depends, at least partially, on the complex nature of the activation mechanism of these proteins involving several Bcl-2 family proteins that specifically interact either with Bax or Bak. With the exception of Bcl-x L that was shown to interact with both Bax and Bak, Bcl-2 only counteracts Bax (Adams and Cory, 1998) , whereas Mcl-1 specifically interacts with Bak . A similar specific interaction profile with antiapoptotic Bcl-2 proteins was demonstrated for certain BH3-only proteins Certo et al., 2006) , and explained the necessity for a simultaneous suppression of at least two antiapoptotic Bcl-2 proteins in order to accomplish a sufficient apoptosis sensitization (Willis et al., 2007) .
A detailed analysis, however, in which an activation and requirement of Bax and Bak for apoptosis induction are compared within one experimental model system is still lacking. This prompted us to simultaneously study the clustering of Bax and Bak in response to different apoptosis inducing stimuli. As active caspases might contribute to mitochondria activation (Lakhani et al., 2006) , we have chosen the MCF-7 breast carcinoma cells that due to the lack of a functional caspase-3 (Ja¨nicke et al., 1998) show also an impaired activation of caspase-9 (Blanc et al., 2000; Essmann et al., 2004) . We established MCF-7 cell lines that stably express green fluorescent protein (GFP)-fusion proteins of either Bax or Bak and found that Bak had a much greater impact in sensitizing the cells to apoptosis than Bax. Even more intriguing was our finding that, almost independently of the death stimulus used, clustering of Bak reproducibly occurred prior to an oligomerization of Bax. Together with the fact that we also observed a partially caspase-dependent activation of Bax, our data reveal a before unrecognized preferential engagement of Bak that appears to be common for apoptosis induction by various death stimuli.
Results
Enhanced sensitivity of MCF-7/GFP-Bak cells to staurosporine-induced apoptosis To comparatively analyse whether Bax and Bak exert unique or redundant functions, we generated MCF-7 breast carcinoma cells stably expressing GFP-fusion proteins of either Bax or Bak. As MCF-7 cells display different protein levels of endogenous Bax and Bak (Figure 1a , lower panels), we purposely selected clones that express similar levels of these fusion proteins, as demonstrated by immunoblotting with a GFP antibody ( Figure 1a , upper left panel). In agreement with previously published data (Hsu et al., 1997; Breckenridge et al., 2003) , immunofluorescence studies of untreated transfectants revealed an almost exclusive localization of GFP-Bak at the mitochondria, whereas GFP-Bax was found to be expressed throughout the cellular compartments (Figures 1b and 2c ). More importantly, however, when both cell lines were treated for 3 h with staurosporine (STS), a broad-spectrum kinase inhibitor, almost all GFP-Bak cells showed intensive GFP clustering, whereas this event was only marginally detectable in a few GFP-Bax-expressing cells ( Figure 1b) .
As oligomerization of the multidomain Bcl-2 proteins is usually accompanied by the release of cytochrome c and subsequent activation of the caspase cascade, we next investigated such downstream events including processing of caspase-7 and the caspase substrate PARP. In line with the results obtained before, STS induced these events indeed much earlier and to a much larger extent in cells expressing GFP-Bak than in GFPBax cells (Figure 1c ). Whereas cleavage of caspase-7 and PARP could be easily detected in GFP-Bak cells following a 2 and 3 h STS treatment, respectively, both events were clearly less pronounced in GFP-Bax cells. Even after 6 h, a substantial amount of caspase-7 and PARP remained uncleaved in these cells, whereas both full-length proteins were almost undetectable in GFPBak cells following a 4 h STS treatment. Thus, GFP-Bak cells show an enhanced sensitivity to STS-induced apoptosis that coincides with an earlier oligomerization and activation of this multidomain protein.
The increased apoptosis sensitivity of GFP-Bak cells is not caused by clonal artifacts or by aberrant expression of antiapoptotic Bcl-2 proteins Although we obtained similar results with two additional clones for each transfectant (data not shown), we could not exclude the possibility that the enhanced apoptosis susceptibility of GFP-Bak cells was due to clonal artifacts caused by the selection procedure. Therefore, we performed the following experiments with MCF-7/GFP-Bak and MCF-7/GFP-Bax bulk cultures that were obtained by fluorescence-activated cell sorting. Treating the two cell populations with STS yielded in comparable results to those obtained with the individual clones, as cleavages of caspase-7 and PARP were detected earlier and to a greater extent in the GFPBak population (Figure 2a) . The differential sensitivity These studies firstly confirmed our observation that a 2 h treatment with STS induced the clustering of GFPBak in almost all of the cells, whereas oligomerization of GFP-Bax was only detectable in a small fraction of the cells (Figure 2b ). To avoid misinterpretation of these data, it should be noted that visualization of the diffuse expression pattern of Bax throughout the cell is hampered by our attempt to emphasize on the presentation of cells displaying oligomerized Bax. Secondly, we found that the appearance of either GFP-Bak or GFP-Bax clusters coincided with the release of cytochrome c, since only cells with clustered Bax or Bak showed a diffuse cytochrome c distribution that did not overlap with the expression of the mitochondrial marker protein Tom20 (Figures 2b and c) . Importantly, whereas the majority of GFP-Bax cells showed an intense cytochrome c staining mostly restricted to the mitochondria indicating healthy cells, almost all GFP-Bak cells displayed diffuse and barely detectable cytochrome c levels.
It is well appreciated that the various antiapoptotic Bcl-2 proteins associate with and inhibit certain proapoptotic Bcl-2 proteins (Willis and Adams, 2005) . In order for the cell to survive an overexpression of Bax and Bak, it is conceivable that such a procedure might alter the expression levels of antiapoptotic proteins. Therefore, we analysed whether the preferential activation of Bak is caused by an aberrant expression of certain antiapoptotic Bcl-2 proteins. However, immunoblot analyses did not reveal significant differences in the expression of Mcl-1, Bcl-w, Bcl-x L or Bcl-2 in the two cell populations when compared to the parental MCF-7 cells ( Figure 2d ). Together, these results strongly suggest that the increased sensitivity of GFP-Bak cells to STSinduced apoptosis is neither caused by clonal artifacts nor by altered expression levels of antiapoptotic Bcl-2 proteins.
Clustering of endogenous Bak precedes that of endogenous bax
Next we investigated the activation-induced oligomerization of the endogenous Bax and Bak proteins in the parental MCF-7 cell line. For this purpose, we used activation-specific antibodies specific for the N termini of Bax and Bak that are normally occluded in the inactive proteins (Suzuki et al., 2000) . Intriguingly, a 3 h treatment of MCF-7 cells with STS was clearly sufficient to induce oligomerization of endogenous Bak in the vast majority of cells, whereas clustering of endogenous Bax was only barely detectable, supporting our initial observation ( Figure 3a (GFP) proteins that are expressed to a similar extent, endogenous Bax (endo-Bax) and Bak (endo-Bak) proteins are expressed at different levels. Reprobing the membrane with the b-actin antibody served as loading control. The asterisk (*) denotes GFP-Bax that remained visible even on the stripped blot. (b) GFP-Bak and GFP-Bax cells were either left untreated (control) or were incubated for 3 h with 1 mM STS and analysed by confocal laser scanning microscopy. (c) GFP-Bak and GFP-Bax cells were incubated for the indicated times with 1 mM STS followed by western blotting to detect processing of caspase-7 and PARP.
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We then asked whether activation of Bak alone is sufficient to induce the release of cytochrome c from mitochondria. To avoid the problem of background staining, we performed this experiment with STS-treated GFP-Bax cells, in which an additional staining with cytochrome c antibodies together with antibodies directed against the N terminus of Bak was feasible. Using these conditions, we found that cytochrome c was not only released from cells displaying mitochondrial oligomerization of both, Bak and Bax, but also from cells in which only Bak was activated (Figure 3b ). Cytochrome c release was convincingly visualized by its diffuse distribution within these cells compared to a predominant mitochondrial staining pattern in cells that neither showed an activated Bak or Bax protein (Figure 3b) .
Remarkably, although our results so far show that only expression of Bak, but not that of Bax enhances sensitivity of MCF-7 cells to STS-induced apoptosis and, in addition, clearly demonstrate an activation of Bak prior to Bax in this scenario, they are in contrast to previous studies postulating an essential role for Bax in a variety of apoptosis systems (Lomonosova et al., 2002; Cartron et al., 2003; Yamaguchi et al., 2003; Dansen et al., 2006) . To exclude the possibility that this discrepancy was caused by a nonfunctional GFP-Bax protein, we transfected Bak/Bax double knockout mouse embryonic fibroblasts with this expression construct and compared the cytochrome c staining pattern in untransfected cells and in cells in which overexpression resulted in the spontaneous oligomerization of GFP-Bax. Cytochrome c in untransfected cells or in cells in which Bax was not oligomerized was clearly associated with mitochondria as visualized by co-staining with the mitochondrial marker Tom20 (Figure 3c, upper panel) . In contrast, cells with oligomerized GFP-Bax showed a diffuse and homogenous distribution of cytochrome c indicating its mitochondrial release (Figure 3c, lower panel) . Hence, the GFP-Bax fusion protein used in our study oligomerizes at the mitochondria leading to the release of cytochrome c and can therefore be considered as fully functional.
Preferential activation of Bak is not restricted to staurosporine-induced apoptosis We next analysed whether the preferential activation of Bak can also be observed with other apoptosis inducers. To this end, we treated the sorted GFP-Bak and GFPBax MCF-7 populations with the transcriptional inhibitor actinomycin D (ActD), TNF or TRAIL, as these stimuli were proposed to activate the intrinsic pathway in a Bak-or Bax-dependent manner (Perez and White, 2000; Werner et al., 2002; Adams and Cooper, 2007; Shimazu et al., 2007) . As expected, microscopic examination showed that also ActD efficiently induced the formation of GFP-Bak clusters in the absence of GFPBax oligomerization, which nevertheless was sufficient to induce the release of cytochrome c (Figure 4a ). Surprisingly, we obtained similar results in cells treated with TRAIL (Figure 4a ), which was proposed to induce apoptosis via activation of Bax (Han et al., 2004) . Following treatment with TNF, on the other hand, both Bax and Bak appeared to oligomerize rather simultaneously, although cells displaying only GFP-Bak clusters could also be detected occasionally. These results were further substantiated by immunoblot analyses that also revealed significant differences between these two GFP cell populations with regard to events downstream of the mitochondria. Whereas treatment of GFP-Bak cells with either ActD or TRAIL induced approximately similar cleavage rates of PARP and caspase-7, these events were much less pronounced or even absent in similarly treated GFP-Bax cells and in the parental MCF-7 cells (Figure 4b ). Compared to the latter one, only GFPBak cells were clearly sensitized toward ActD and TRAIL. In contrast, PARP and caspase-7 were processed to a comparable extent in the three cell populations by TNF (Figure 4b ), indicating that this death stimulus does not preferentially activate Bak.
We next compared the sensitivities of MCF-7/GFPBak and MCF-7/GFP-Bax cells toward overexpression of the BH3-only protein Puma that was previously shown to induce apoptosis in a Bax-dependent manner (Yu et al., 2003) . We transduced both cell populations with an adenovirus allowing the inducible expression of Puma in the absence ('on' condition), but not in the presence ('off' condition) of doxycycline. Western blot analyses confirmed expression of Puma in both cell populations 24 and 48 h posttransduction (Figure 4c , upper panels) and revealed that this overexpression resulted in a substantial processing of caspase-7 predominantly in GFP-Bak cells (Figure 4c , lower panels). Caspase-7 in GFP-Bax cells, in contrast, was only marginally processed following Puma induction, indicating that activation of Bak plays also a dominant role in the pathway induced by this BH3-only protein. Consistently, immunofluorescence microscopy revealed the presence of a significantly greater amount of cells displaying GFP-clusters following expression of Puma in GFP-Bak cells than in GFP-Bax cells (data not shown). As, regardless of the death stimulus used, we never detected cells that only displayed oligomerized Bax in the absence of Bak clusters, our results provide strong evidence that the preferential engagement of Bak represents a mechanism common for the activation of the intrinsic pathway by diverse apoptotic stimuli. 
The differential apoptosis inhibitory potentials of Bcl-2 and Bcl-x L correlate with a predominant role of Bak Having established a predominant role for Bak, we thought to further substantiate this result by taking advantage of the fact that Bak and Bax are inhibited to varying degrees by distinct antiapoptotic Bcl-2 proteins. In order to choose the appropriate Bcl-2 proteins for this line of investigation, we first analysed the distribution of endogenous Bcl-2, Bcl-x L , Bcl-w and Mcl-1 in the two GFP cell populations. Although endogenous Mcl-1 could be only detected very poorly by confocal laser scanning microscopy, initial experiments provided evidence that from the four Bcl-2 proteins tested, Bcl-2 and Bcl-x L showed, at least in our hands, the most distinct differences with regard to their colocalization with Bax and Bak, respectively (data not shown). Therefore, we transfected GFP-Bak and GFP-Bax cells with plasmids encoding DsRedm-Bcl-x L and -Bcl-2 fusion proteins and analysed these cells by confocal microscopy. As shown in Figure 5a , DsRedm-Bcl-2 specifically colocalized only with Bax, whereas DsRedm-Bcl-x L was predominantly associated with Bak and to a lesser extent also with Bax. Based on these findings, one would anticipate a stronger inhibition of STS-induced apoptosis with Bcl-x L than with Bcl-2. Indeed, overexpression of Bcl-x L resulted in an almost complete inhibition of STS-induced apoptosis of GFP-Bak cells, as evidenced by the lack of PARP and caspase-7 cleavage (Figure 5b ). In contrast, both events were only partially reduced following overexpression of Bcl-2 that only inhibits Bax, but not Bak. Probably due to the high endogenous Bak levels, similar results were also obtained when GFP-Bax cells were treated with STS in the presence of these antiapoptotic proteins, further indicating that Bak but not Bax is the crucial determinant for activation of the intrinsic pathway (Figure 5b ). 
The activation of Bax depends, at least partially, on active caspases As we never observed an activation of Bax prior to Bak and because expression of Bak had reproducibly a greater impact on sensitizing MCF-7 cells, we finally asked whether activation of Bax might require an event that takes place downstream of the mitochondria such as activation of caspases. Therefore, we performed immunoprecipitation studies with antibodies recognizing only the active forms of either Bax or Bak in the absence or presence of the caspase-inhibitory peptide zVAD-fmk. Indeed, whereas caspase inhibition had no effect on the STS-induced activation of Bak in MCF-7 cells, zVAD-fmk reproducibly attenuated the amount of active Bax when compared to the levels of Bax precipitated in the absence of this compound (Figure 6a ). Our finding that activation of Bax appears to require, at least partially, the presence of active caspases was further substantiated by comparing STS-induced oligomerization of Bax in the parental caspase-3-deficient MCF-7 cells and MCF-7/casp-3 cells. Consistent with the aforementioned results, following treatment with STS immunofluorescence studies revealed significantly higher numbers of cells with oligomerized Bax in the MCF-7/casp-3 cultures (36%) than in the parental MCF-7 cells (15%) (Figures 6b and c) . Hence, active caspases appear to be required for an efficient activation of Bax.
Discussion
In an attempt to decipher possible individual roles of the multidomain proteins Bax and Bak, we studied their activation-induced oligomerization in MCF-7 cells. Although the expression levels of endogenous Bax and Bak differed in these cells, we circumvented this problem not only by examining their activation on the single-cell level, but also by comparing oligomerization of GFP-Bax and GFP-Bak fusion proteins stably overexpressed in these cells. Interestingly, we found a reproducibly higher potential of GFP-Bak to sensitize MCF-7 cells to apoptosis compared to the GFP-Bax. This was not due to a nonfunctional GFP-Bax protein, as firstly translocation and oligomerization of this fusion protein was observed in MCF-7/GFP-Bax cells following apoptosis induction, and secondly, overexpression of this construct in Bax/Bak double knockout MEFs efficiently induced the formation of GFP clusters at the mitochondria resulting in the release of cytochrome c. The enhanced sensitizing effect of GFP-Bak was also not due to clonal artifacts or a deregulated expression of antiapoptotic Bcl-2 proteins, but was rather caused by the fact that, independent of the death stimulus used, oligomerization of either the endogenous Bak or the GFP-Bak fusion protein was always detected prior to GFP-Bax clustering and even prior to oligomerization of endogenous Bax. More intriguingly, as oligomerization of either Bak protein resulted in an efficient release of cytochrome c even in the complete absence of Bax clustering, our results provide strong evidence for a pivotal role of Bak in this process. This assumption was further substantiated by our finding that inhibition of Bak activation by overexpression of Bcl-x L completely prevented STS-induced PARP and caspase-7 cleavage, whereas the sole inhibition of Bax by Bcl-2 had only a marginal effect. Although a Bak dependency was already demonstrated in certain apoptosis systems (Lindenboim et al., Pardo et al., 2006) , the here-described preferential engagement of the Bak pathway was rather a surprising result, as it was observed even in apoptosis induced by TRAIL and following overexpression of Puma that were both shown to critically depend on Bax (Werner et al., 2002; Yu et al., 2003; Han et al., 2004) . Nevertheless, our results do not entirely contradict these findings as their conclusions were reached in most cases solely by examining the final steps in apoptosis execution. However, the preferential order of the activation of Bak and Bax within a single cell, as described in the present study, was not systematically analysed before. There are several possibilities that could explain the differential activation of Bak and Bax. The activation of Bax has been reported to be inhibited by various cytosolic retention factors. Different isoforms of 14-3-3 and Hsp70 proteins, the apoptosis repressor with caspase-recruitment domain, and Ku70 were identified as Bax-interacting proteins whose overexpression inhibits Bax-dependent apoptosis and its translocation to mitochondria (reviewed in Lucken-Ardjomande and Martinou, 2005) . Furthermore, overexpression of hexokinase II, a glycolytic enzyme associated with the mitochondrial outer membrane, prevents the mitochondrial translocation of Bax (Pastorino et al., 2002) . In addition, activation of Bax and Bak not only depends on the death stimulus and the hereby activated BH3-only proteins, but also on the cellular system and on the presence and abundance of antiapoptotic Bcl-2 proteins (Letai, 2005; Konopleva et al., 2006) . For instance, Bax is inhibited by numerous Bcl-2 proteins including Bcl-2 itself, Bcl-x L and Bcl-w, whereas only Bcl-x L and Mcl-1 were shown to efficiently block Bak activation . Due to the limited number of Bakinhibiting Bcl-2 proteins, it is plausible that activation of this multidomain protein might be achieved prior to that of Bax. In favor of this theory are also several findings demonstrating a certain Bak dependency even in apoptosis systems that were believed to be executed before via Bax. For example, although apoptosis induction in prostate carcinoma cells by Nbk/Bik was recently shown to critically depend on the presence of Bax (Gillissen et al., 2003) , downregulation of Mcl-1 expression rendered also Bax-deficient cells sensitive toward this BH3-only protein (Gillissen and Daniel, unpublished data) . In addition, based on its antiapoptotic targets Bcl-2, Bcl-x L and Bcl-w, it was initially assumed that sensitization to anticancer drug-and radiation-induced apoptosis by the BH3-mimetic ABT-737 was mediated via activation of Bax (Oltersdorf et al., 2005) . As certain cell types and especially those expressing high levels of Mcl-1 proved refractory to ABT-737 and because downregulation of Mcl-1 greatly sensitized even Bcl-2 overexpressing cells toward this compound, it became clear that ABT-737-mediated sensitization requires also the activation of Bak (van Delft et al., 2006) . Whether Bak is activated prior to Bax also in these systems remains to be investigated.
Another intriguing finding of our study was the observation that, independent of the death stimulus, we never detected cells displaying only oligomerized Bax in the absence of Bak clusters. On the other hand, oligomerization of Bak was clearly evident also in cells that did not show Bax activation leading nevertheless to cytochrome c release, thereby suggesting that the activation of Bax might occur downstream of Bak. In fact, we found an increased number of cells displaying an oligomerized endogenous Bax protein in STS-treated MCF-7/casp-3 than in parental MCF-7 cells. Additionally, zVAD-fmk attenuated activation of Bax, but had no influence on the activation of Bak. Together, these results are not only consistent with the aforementioned notion, but furthermore indicate that this event might even depend, at least partially, on the presence of an active caspase-3 enzyme. This is plausible in view of the fact that monomeric Bax, in contrast to Bak, is 
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D Neise et al expressed throughout the cellular compartments. As only mitochondria-associated Bax can be inhibited by antiapoptotic Bcl-2 proteins, it is likely that cytosolic Bax is activated in a different manner, perhaps requiring a yet unknown caspase-dependent event. Such a conclusion was drawn from experiments showing a delayed Bax translocation and cytochrome c release in cells deficient for caspase-3 and -7 (Lakhani et al., 2006) . Unfortunately, activation of Bak was not analysed in this system. In addition, during preparation of our manuscript it was published that the activation of Bax in Neisseria gonorrhoeae-and cisplatin-induced apoptosis, but not in apoptosis induced by TNF, requires Bak and active caspases (Kepp et al., 2007) . Consistent with this study, we could also not detect a preferential activation of Bak when TNF was used to induce apoptosis. The reason for this is presently unknown, but might be due to the sequential complex formation in TNF signaling that clearly differs from the DISC assembly in TRAILinduced apoptosis (Micheau and Tschopp, 2003) . What are the caspase-mediated events that lead to the activation of Bax? One candidate would be Bcl-2 that upon cleavage by caspases looses its Bax-inhibitory potential (Cheng et al., 1997) . However, Bcl-2 was not cleaved in our system strongly arguing against this possibility. Another likely candidate is the BH3-only protein Bid that requires cleavage by caspase-8 in order to generate a truncated Bid molecule (tBid) that is able to activate Bax (Letai et al., 2002) . Caspase-8 is indeed activated downstream of the intrinsic death pathway in an amplification loop via the combined processing effort by caspase-3 and -6 (Murphy et al., 2004; Sohn et al., 2005) . Although the appearance of tBid was readily detectable in TNF-and TRAIL-induced apoptosis, it was not observed when the cells were incubated with ActD even at a time point at which cells with oligomerized Bax could be visualized (data not shown). Together with the fact that the loss of Bid has only minimal physiological consequences (Yin et al., 1999) which is in sharp contrast to the profound effect of a Bax/Bak deficiency (Lindsten et al., 2000) , these data also argue against an important role of Bid for the activation of Bax downstream of mitochondria and caspases. Perhaps other yet unknown Bid-like molecules with a redundant function are required. It is also conceivable that other proteases such as calpains participate in the downstream activation of Bax (Panaretakis et al., 2002) .
In summary, we have shown that the greater potential of Bak to sensitize MCF-7 cells to apoptosis is most likely caused by a preferential engagement of this multidomain Bcl-2 protein by various death stimuli. The secondary activation of Bax that occurs then, at least partially, downstream of Bak and caspases might represent a positive feedback loop resulting in the amplification of the death signal.
Materials and methods
For descriptions of experimental procedures, see Supplementary Material on the Oncogene website.
